Iovance Biotherapeutics Inc. buy BiotechBee
Start price
24.06.23
/
50%
€7.14
Target price
30.11.25
€9.00
Performance (%)
7.45%
End price
14.12.24
€7.67
Summary
This prediction ended on 14.12.24 with a price of €7.67. The BUY prediction by BiotechBee finished with a performance of 7.45%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Iovance Biotherapeutics Inc. | 17.667% | 17.667% | 206.661% | 22.763% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % | 64,71 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % | 88,24 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % | 79,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % | 69,60 % |
According to BiotechBee what are the pros and cons of Iovance Biotherapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Lion Biotechnologies Inc diskutieren
Buy mit Kursziel 9,0
In the thread Trading Lion Biotechnologies Inc
Buy beendet

